Esophageal carcinoma

1 paper

Trial sponsors

Merck & Co.
Company2 trialsPhase 3751 people
Fudan University
1 trialPhase 3432 people
Zhejiang Cancer Hospital
1 trialPhase 3300 people
National Cancer Institute
4 trialsPhase 230,582 people
Academisch Medisch Centrum - Universiteit van Amsterdam
1 trialPhase 2290 people
Spanish Cooperative Group for the Treatment of Digestive Tumours
1 trialPhase 250 people
University of Rochester
1 trialPhase 240 people
Tianjin Medical University Cancer Institute and Hospital
1 trialPhase 239 people

Latest

1 in 12 months

Frontiers in Cell and Developmental Biology1 Jan

Aging-associated mechanisms and metabolic vulnerabilities in esophageal carcinoma: an integrative review

ReviewMechanisms